Evidence map›Paper›PMID 34001508›Full record

ArticleAntimicrobial agents and chemotherapy2021

A Novel Series of Indole Alkaloid Derivatives Inhibit Dengue and Zika Virus Infection by Interference with the Viral Replication Complex.

Antonios Fikatas, Peter Vervaeke, Eef Meyen, Nuria Llor, Sergi Ordeix, Ine Boonen, Magda Bletsa, Liana Eleni Kafetzopoulou, Philippe Lemey, Mercedes Amat and 2 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alkaloids as potential antivirals. A comprehensive review.Natural products and bioprospecting · 2023
    Review
  7. Article
  8. Article
  9. Drugs to limit Zika virus infection and implication for maternal-fetal health.Frontiers in virology (Lausanne, Switzerland) · 2022
    Article
  10. Dengue virus NS4B protein as a target for developing antivirals.Frontiers in cellular and infection microbiology · 2022
    Review
  11. Bisbenzylisoquinoline Alkaloids ofFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Antonios FikatasLaboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Peter VervaekeLaboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Eef MeyenLaboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Nuria LlorLaboratory of Organic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine, Barcelona, Spain.
Sergi OrdeixLaboratory of Organic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine, Barcelona, Spain.
Ine BoonenLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Magda BletsaLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Liana Eleni KafetzopoulouLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Philippe LemeyLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Mercedes AmatLaboratory of Organic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine, Barcelona, Spain.
Christophe Pannecouque *Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Dominique Schols *Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute for Medical Research, Leuven, Belgium.
Rega Institute for Medical Research · BEInstitute for Research in Biomedicine · ES

Funding

Wellcome TrustWellcome Trust 206298/Z/17/Z
6 · The paper itself

Abstract

Here, we identified a novel class of compounds which demonstrated good antiviral activity against dengue and Zika virus infection. These derivatives constitute intermediates in the synthesis of indole (ervatamine-silicine) alkaloids and share a tetracyclic structure, with an indole and a piperidine fused to a seven-membered carbocyclic ring. Structure-activity relationship studies indicated the importance of substituent at position C-6 and especially the presence of a benzyl ester for the activity and cytotoxicity of the molecules. In addition, the stereochemistry at C-7 and C-8, as well as the presence of an oxazolidine ring, influenced the potency of the compounds. Mechanism of action studies with two analogues of this family (compounds 22 and

Indexed as

DengueZika VirusZika Virus InfectionHumansIndole AlkaloidsViral Nonstructural ProteinsVirus ReplicationIndole AlkaloidsViral Nonstructural Proteinscross resistancedengue virusindole alkaloidsmechanisms of actionNS4B proteinSAR studiesZika virus

Identifiers

PMID34001508
PMCPMC8284442
OpenAlexW3163443158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.